Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Copper Histidinate Treatment for Menkes Disease

NCT04074512 is registered in ClinicalTrials.gov with Sentynl Therapeutics, Inc. as lead sponsor.

NCT NCT04074512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04074512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Copper Histidinate Treatment for Menkes Disease
Lead sponsor
Sentynl Therapeutics, Inc.
Phase
Expanded access
Overall status
Approved for marketing
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

menkes disease